PlainRecalls
FDA Drug Moderate Class II Terminated

Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0810-16

Reported: August 19, 2020 Initiated: August 4, 2020 #D-1494-2020

Product Description

Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0810-16

Reason for Recall

Subpotent drug: Out of specification for assay at the 15-month test interval.

Details

Units Affected
7416 bottles
Distribution
Nationwide USA
Location
Greenville, SC

Frequently Asked Questions

What product was recalled?
Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0810-16. Recalled by PAI Holdings, LLC. dba Pharmaceutical Associates Inc. Units affected: 7416 bottles.
Why was this product recalled?
Subpotent drug: Out of specification for assay at the 15-month test interval.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 19, 2020. Severity: Moderate. Recall number: D-1494-2020.